Cue Biopharma
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
Revenue | $7,877 | $5,686 | $21,942 | $2,149 |
Gross Profit | 7,841 | 5,686 | 21,942 | 2,069 |
EBITDA | -87,695 | -4,245 | 3,342 | -7,294 |
EBIT | -87,731 | -5,174 | 2,136 | -7,373 |
Net Income | -153,067 | -5,178 | 1,585 | -7,448 |
Net Change In Cash | 7,877 | 5,686 | 21,942 | 2,149 |
Free Cash Flow | -29,004 | -11,063 | -1,076 | -9,024 |
Cash | 17,392 | 16,379 | 27,136 | 11,701 |
Basic Shares | 6,340 | 4,807 | 3,683 | 3,362 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $27,466 | $9,287 | $5,490 | $1,245 |
Gross Profit | 27,466 | 9,287 | -32,607 | 1,245 |
EBITDA | -22,265 | -37,528 | -46,052 | -50,491 |
EBIT | -25,745 | -39,878 | -49,488 | -52,297 |
Net Income | -26,602 | -40,674 | -50,733 | -53,010 |
Net Change In Cash | 27,466 | 9,287 | 5,490 | 1,245 |
Cost of Revenue | -12,756 | |||
Free Cash Flow | -21,864 | -36,395 | -39,961 | -41,977 |
Cash | 27,136 | 22,459 | 48,514 | 51,614 |
Basic Shares | 3,157 | 1,877 | 1,525 | 1,188 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | -$13.81 |
2026-03-31 | -$1.08 |
2025-12-31 | $0.01 |
2025-09-30 | -$2.10 |